Medicenna Therapeutics Corp. (TSX:MDNA)
Canada flag Canada · Delayed Price · Currency is CAD
0.3500
+0.0050 (1.45%)
Jul 24, 2026, 3:57 PM EST

Medicenna Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
3253771306192
Market Cap Growth
-54.43%-30.35%-40.82%111.36%-33.26%-66.44%
Enterprise Value
26.1747.2651.98112.5427.6871.28
Last Close Price
0.350.640.981.860.881.65

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
13.0221.514.0124.952.084.41
P/TBV Ratio
11.9621.873.9525.231.944.31

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.020.020.01000
Net Debt / Equity Ratio
-2.47-2.47-1.29-3.27-1.14-0.99
Net Debt / EBITDA Ratio
0.270.271.210.912.060.92
Net Debt / FCF Ratio
0.340.341.491.042.650.87
Quick Ratio
1.391.396.216.349.078.33
Current Ratio
1.521.526.356.669.578.92
Return on Equity (ROE)
-712.61%-287.13%-272.58%-16.35%-99.35%-76.21%
Return on Assets (ROA)
-208.35%-121.71%-85.89%-67.20%-54.43%-68.40%
Return on Invested Capital (ROIC)
-10725.80%-9704.33%-12874.40%-31650.80%-9032.13%-10285.10%
Return on Capital Employed (ROCE)
-399.20%-166.45%-101.48%-76.35%-60.97%-76.21%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Buyback Yield / Dilution
-8.51%-8.51%-10.10%-7.57%-19.25%-9.31%
Total Shareholder Return
-8.51%-8.51%-10.10%-7.57%-19.25%-9.31%